CAPR: Capricor Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Capricor Therapeutics Inc (CAPR).
$627.48M Market Cap.
CAPR Market Cap. (MRY)
CAPR Shares Outstanding (MRY)
CAPR Assets (MRY)
Total Assets
$170.48M
Total Liabilities
$25.02M
Total Investments
$140.23M
CAPR Income (MRY)
Revenue
$22.27M
Net Income
-$40.47M
Operating Expense
$64.84M
CAPR Cash Flow (MRY)
CF Operations
-$40.00M
CF Investing
-$116.18M
CF Financing
$152.77M
CAPR Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $170,481,086 (190.26%) | $58,734,327 (17.25%) | $50,094,910 (21.21%) | $41,330,323 (19.39%) |
Assets Current | $163,385,267 (221.27%) | $50,855,472 (18.58%) | $42,888,734 (17.71%) | $36,436,961 (8.20%) |
Assets Non-Current | $7,095,819 (-9.94%) | $7,878,855 (9.33%) | $7,206,176 (47.26%) | $4,893,362 (419.62%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $145,462,336 (543.60%) | $22,601,467 (91.76%) | $11,786,094 (-62.43%) | $31,367,966 (11.23%) |
Property Plant & Equipment Net | $6,874,119 (-9.68%) | $7,610,683 (9.70%) | $6,938,004 (50.25%) | $4,617,640 (442.71%) |
Cash & Equivalents | $11,286,996 (-23.19%) | $14,694,857 (53.02%) | $9,603,242 (-72.47%) | $34,885,274 (6.79%) |
Accumulated Other Comprehensive Income | $1,026,955 (335.50%) | $235,813 (124.06%) | $105,244 (0%) | $0 (0%) |
Deferred Revenue | $12,000,000 (-50.56%) | $24,270,465 (-11.58%) | $27,448,531 (0%) | $0 (0%) |
Total Investments | $140,228,881 (465.60%) | $24,792,846 (-22.08%) | $31,818,020 (0%) | $0 (0%) |
Investments Current | $140,228,881 (465.60%) | $24,792,846 (-22.08%) | $31,818,020 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $10,368,489 (-0.03%) | $10,371,993 (1794.15%) | $547,580 (39.78%) | $391,750 (0%) |
Trade & Non-Trade Payables | $8,191,377 (31.06%) | $6,250,241 (26.94%) | $4,923,917 (32.51%) | $3,715,759 (36.38%) |
Accumulated Retained Earnings (Deficit) | -$199,834,539 (-25.39%) | -$159,367,353 (-16.26%) | -$137,079,811 (-26.85%) | -$108,060,279 (-22.74%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $1,451,114 (-35.10%) | $2,235,895 (-12.66%) | $2,560,109 (-10.81%) | $2,870,339 (802.17%) |
Debt Current | $834,799 (11.44%) | $749,112 (9.83%) | $682,039 (63.31%) | $417,632 (69.29%) |
Debt Non-Current | $616,315 (-58.55%) | $1,486,783 (-20.83%) | $1,878,070 (-23.43%) | $2,452,707 (3331.75%) |
Total Liabilities | $25,018,750 (-30.76%) | $36,132,860 (-5.68%) | $38,308,816 (284.54%) | $9,962,357 (55.20%) |
Liabilities Current | $21,026,176 (-32.76%) | $31,269,818 (32.57%) | $23,586,555 (470.63%) | $4,133,391 (39.11%) |
Liabilities Non-Current | $3,992,574 (-17.90%) | $4,863,042 (-66.97%) | $14,722,261 (152.57%) | $5,828,966 (69.07%) |
CAPR Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $22,270,465 (-11.55%) | $25,178,066 (886.81%) | $2,551,469 (941.85%) | $244,898 (-21.06%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $14,866,722 (16.07%) | $12,807,886 (22.78%) | $10,431,903 (37.04%) | $7,612,295 (37.33%) |
Research & Development Expense | $49,968,585 (37.10%) | $36,448,039 (67.06%) | $21,816,949 (60.76%) | $13,571,045 (60.47%) |
Operating Expenses | $64,835,307 (31.63%) | $49,255,925 (52.74%) | $32,248,852 (52.24%) | $21,183,340 (51.31%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$40,467,186 (-81.57%) | -$22,287,542 (23.20%) | -$29,019,532 (-44.93%) | -$20,022,520 (-46.61%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$40,467,186 (-81.57%) | -$22,287,542 (23.20%) | -$29,019,532 (-44.93%) | -$20,022,520 (-46.61%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$40,467,186 (-81.57%) | -$22,287,542 (23.20%) | -$29,019,532 (-44.93%) | -$20,022,520 (-46.61%) |
Weighted Average Shares | $35,218,628 (31.52%) | $26,778,360 (9.06%) | $24,552,688 (6.34%) | $23,089,323 (48.28%) |
Weighted Average Shares Diluted | $35,218,628 (31.52%) | $26,778,360 (9.06%) | $24,552,688 (6.34%) | $23,089,323 (48.28%) |
Earning Before Interest & Taxes (EBIT) | -$40,467,186 (-81.57%) | -$22,287,542 (23.20%) | -$29,019,532 (-44.93%) | -$20,022,520 (-46.61%) |
Gross Profit | $22,270,465 (-11.55%) | $25,178,066 (886.81%) | $2,551,469 (941.85%) | $244,898 (-21.06%) |
Operating Income | -$42,564,842 (-76.78%) | -$24,077,859 (18.92%) | -$29,697,383 (-41.83%) | -$20,938,442 (-52.95%) |
CAPR Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$116,183,868 (-2374.45%) | $5,108,210 (114.56%) | -$35,072,507 (-2831.78%) | -$1,196,286 (-121.99%) |
Net Cash Flow from Financing | $152,771,749 (497.23%) | $25,579,950 (424.84%) | $4,873,838 (-75.90%) | $20,225,010 (-39.41%) |
Net Cash Flow from Operations | -$39,995,742 (-56.25%) | -$25,596,545 (-620.61%) | $4,916,637 (129.25%) | -$16,809,324 (-67.18%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$3,407,861 (-166.93%) | $5,091,615 (120.14%) | -$25,282,032 (-1239.14%) | $2,219,400 (-92.28%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$114,644,893 (-1702.14%) | $7,155,743 (122.56%) | -$31,712,776 (0%) | $0 (0%) |
Capital Expenditure | -$1,538,975 (24.84%) | -$2,047,533 (39.06%) | -$3,359,731 (-180.85%) | -$1,196,286 (-118.46%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $152,771,749 (497.23%) | $25,579,950 (424.84%) | $4,873,838 (-75.90%) | $20,225,010 (-38.83%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $9,765,164 (32.10%) | $7,392,396 (65.80%) | $4,458,578 (50.34%) | $2,965,692 (51.88%) |
Depreciation Amortization & Accretion | $1,425,214 (33.34%) | $1,068,882 (100.49%) | $533,131 (116.99%) | $245,697 (70.75%) |
CAPR Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (0.00%) |
Profit Margin | -181.70% (-105.31%) | -88.50% (92.22%) | -1137.40% (86.09%) | -8175.90% (-85.74%) |
EBITDA Margin | -175.30% (-107.95%) | -84.30% (92.45%) | -1116.50% (86.17%) | -8075.50% (-85.40%) |
Return on Average Equity (ROAE) | -66.40% (77.84%) | -299.70% (-82.19%) | -164.50% (-183.13%) | -58.10% (-6.22%) |
Return on Average Assets (ROAA) | -46.10% (-1.32%) | -45.50% (10.96%) | -51.10% (-7.13%) | -47.70% (-6.71%) |
Return on Sales (ROS) | -181.70% (-105.31%) | -88.50% (92.22%) | -1137.40% (86.09%) | -8175.90% (-85.74%) |
Return on Invested Capital (ROIC) | -94.50% (74.11%) | -365.00% (-102.78%) | -180.00% (96.94%) | -5873.70% (-397.09%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -12 (-103.67%) | -5.89 (-80.13%) | -3.27 (2.88%) | -3.37 (13.60%) |
Price to Sales Ratio (P/S) | 21.82 (319.59%) | 5.2 (-86.00%) | 37.15 (-86.55%) | 276.24 (60.47%) |
Price to Book Ratio (P/B) | 4.31 (-35.24%) | 6.66 (-19.41%) | 8.27 (266.45%) | 2.26 (-9.29%) |
Debt to Equity Ratio (D/E) | 0.17 (-89.24%) | 1.6 (-50.80%) | 3.25 (922.01%) | 0.32 (39.47%) |
Earnings Per Share (EPS) | -1.15 (-38.55%) | -0.83 (29.66%) | -1.18 (-35.63%) | -0.87 (1.14%) |
Sales Per Share (SPS) | 0.63 (-32.77%) | 0.94 (803.85%) | 0.1 (845.45%) | 0.01 (-45.00%) |
Free Cash Flow Per Share (FCFPS) | -1.18 (-14.24%) | -1.03 (-1738.10%) | 0.06 (108.08%) | -0.78 (-14.54%) |
Book Value Per Share (BVPS) | 4.13 (389.34%) | 0.84 (75.83%) | 0.48 (-64.68%) | 1.36 (-24.96%) |
Tangible Assets Book Value Per Share (TABVPS) | 4.84 (120.75%) | 2.19 (7.50%) | 2.04 (13.97%) | 1.79 (-19.48%) |
Enterprise Value Over EBIT (EV/EBIT) | -14 (-133.33%) | -6 (-100.00%) | -3 (-200.00%) | -1 (66.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -14.36 (-111.63%) | -6.79 (-110.58%) | -3.22 (-113.02%) | -1.51 (41.83%) |
Asset Turnover | 0.25 (-50.58%) | 0.51 (1042.22%) | 0.04 (650.00%) | 0.01 (-40.00%) |
Current Ratio | 7.77 (377.92%) | 1.63 (-10.56%) | 1.82 (-79.38%) | 8.81 (-22.23%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$41,534,717 (-50.25%) | -$27,644,078 (-1875.58%) | $1,556,906 (108.65%) | -$18,005,610 (-69.83%) |
Enterprise Value (EV) | $560,755,851 (289.40%) | $144,005,685 (56.87%) | $91,798,569 (206.84%) | $29,917,866 (-14.89%) |
Earnings Before Tax (EBT) | -$40,467,186 (-81.57%) | -$22,287,542 (23.20%) | -$29,019,532 (-44.93%) | -$20,022,520 (-46.61%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$39,041,972 (-84.00%) | -$21,218,660 (25.51%) | -$28,486,401 (-44.04%) | -$19,776,823 (-46.35%) |
Invested Capital | $139,619,028 (830.45%) | $15,005,547 (-22.91%) | $19,465,222 (275.63%) | $5,181,997 (837.79%) |
Working Capital | $142,359,091 (626.85%) | $19,585,654 (1.47%) | $19,302,179 (-40.25%) | $32,303,570 (5.20%) |
Tangible Asset Value | $170,481,086 (190.26%) | $58,734,327 (17.25%) | $50,094,910 (21.21%) | $41,330,323 (19.39%) |
Market Capitalization | $627,484,730 (316.72%) | $150,577,129 (54.55%) | $97,431,812 (37.70%) | $70,757,024 (0.89%) |
Average Equity | $60,916,135 (719.01%) | $7,437,806 (-57.85%) | $17,646,062 (-48.80%) | $34,466,213 (38.07%) |
Average Assets | $87,788,648 (79.38%) | $48,940,316 (-13.77%) | $56,752,627 (35.20%) | $41,976,324 (37.37%) |
Invested Capital Average | $42,826,103 (601.35%) | $6,106,220 (-62.13%) | $16,124,367 (4630.19%) | $340,882 (149.35%) |
Shares | 45,469,908 (47.66%) | 30,792,869 (21.99%) | 25,241,402 (4.52%) | 24,149,155 (18.10%) |
